These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Genome-wide association study confirming association of HLA-DP with protection against chronic hepatitis B and viral clearance in Japanese and Korean. Nishida N, Sawai H, Matsuura K, Sugiyama M, Ahn SH, Park JY, Hige S, Kang JH, Suzuki K, Kurosaki M, Asahina Y, Mochida S, Watanabe M, Tanaka E, Honda M, Kaneko S, Orito E, Itoh Y, Mita E, Tamori A, Murawaki Y, Hiasa Y, Sakaida I, Korenaga M, Hino K, Ide T, Kawashima M, Mawatari Y, Sageshima M, Ogasawara Y, Koike A, Izumi N, Han KH, Tanaka Y, Tokunaga K, Mizokami M. PLoS One; 2012; 7(6):e39175. PubMed ID: 22737229 [Abstract] [Full Text] [Related]
4. Association of human leukocyte antigen DP/DQ gene polymorphisms with chronic hepatitis B in Chinese Han and Uygur populations. Xiang X, Guo Y, Yang L, Ge Q, Mijit S, Xu F. Infect Genet Evol; 2016 Sep; 43():407-11. PubMed ID: 27291710 [Abstract] [Full Text] [Related]
5. HLA-DP genes polymorphisms associate with hepatitis B surface antigen kinetics and seroclearance during nucleot(s)ide analogue therapy. Hosaka T, Suzuki F, Kobayashi M, Fukushima T, Kawamura Y, Sezaki H, Akuta N, Suzuki Y, Saitoh S, Arase Y, Ikeda K, Kobayashi M, Kumada H. Liver Int; 2015 Apr; 35(4):1290-302. PubMed ID: 25103089 [Abstract] [Full Text] [Related]
6. Genetic variants in human leukocyte antigen/DP-DQ influence both hepatitis B virus clearance and hepatocellular carcinoma development. Hu L, Zhai X, Liu J, Chu M, Pan S, Jiang J, Zhang Y, Wang H, Chen J, Shen H, Hu Z. Hepatology; 2012 May; 55(5):1426-31. PubMed ID: 22105689 [Abstract] [Full Text] [Related]
7. Strong influence of human leukocyte antigen-DP variants on response to hepatitis B vaccine in a Japanese population. Okada Y, Uno N, Sato S, Mori S, Sasaki D, Kaku N, Kosai K, Morinaga Y, Hasegawa H, Yanagihara K. Vaccine; 2017 Oct 09; 35(42):5662-5665. PubMed ID: 28882445 [Abstract] [Full Text] [Related]
8. Relationship between HLA-DPA1 mRNA expression and susceptibility to hepatitis B. Ou G, Liu X, Yang L, Yu H, Ji X, Liu F, Xu H, Qian L, Wang J, Liu Z. J Viral Hepat; 2019 Jan 09; 26(1):155-161. PubMed ID: 30267609 [Abstract] [Full Text] [Related]
9. A common HLA-DPA1 variant is associated with hepatitis B virus infection but fails to distinguish active from inactive Caucasian carriers. Vermehren J, Lötsch J, Susser S, Wicker S, Berger A, Zeuzem S, Sarrazin C, Doehring A. PLoS One; 2012 Jan 09; 7(3):e32605. PubMed ID: 22448225 [Abstract] [Full Text] [Related]
10. Role of HLA-DP polymorphisms on chronicity and disease activity of hepatitis B infection in Southern Chinese. Wong DK, Watanabe T, Tanaka Y, Seto WK, Lee CK, Fung J, Lin CK, Huang FY, Lai CL, Yuen MF. PLoS One; 2013 Jan 09; 8(6):e66920. PubMed ID: 23825586 [Abstract] [Full Text] [Related]
11. Association of variants in HLA-DP on chromosome 6 with chronic hepatitis B virus infection and related phenotypes. Jiang X, Ma Y, Cui W, Li MD. Amino Acids; 2014 Aug 09; 46(8):1819-26. PubMed ID: 24846544 [Abstract] [Full Text] [Related]
12. Protective effects of HLA-DPA1/DPB1 variants against Hepatitis B virus infection in an Indonesian population. Wasityastuti W, Yano Y, Ratnasari N, Triyono T, Triwikatmani C, Indrarti F, Heriyanto DS, Yamani LN, Liang Y, Utsumi T, Hayashi Y. Infect Genet Evol; 2016 Jul 09; 41():177-184. PubMed ID: 27051043 [Abstract] [Full Text] [Related]
13. HLA-DP and IL28B polymorphisms: influence of host genome on hepatitis B surface antigen seroclearance in chronic hepatitis B. Seto WK, Wong DK, Kopaniszen M, Proitsi P, Sham PC, Hung IF, Fung J, Lai CL, Yuen MF. Clin Infect Dis; 2013 Jun 09; 56(12):1695-703. PubMed ID: 23449268 [Abstract] [Full Text] [Related]
14. Genetic polymorphisms of HLA-DP and isolated anti-HBc are important subsets of occult hepatitis B infection in Indonesian blood donors: a case-control study. Mardian Y, Yano Y, Wasityastuti W, Ratnasari N, Liang Y, Putri WA, Triyono T, Hayashi Y. Virol J; 2017 Oct 23; 14(1):201. PubMed ID: 29061159 [Abstract] [Full Text] [Related]
15. Role of HLA-DP and HLA-DQ on the clearance of hepatitis B virus and the risk of chronic infection in a multiethnic population. Trinks J, Nishida N, Hulaniuk ML, Caputo M, Tsuchiura T, Marciano S, Haddad L, Blejer J, Bartoli S, Ameigeiras B, Frías SE, Vistarini C, Heinrich F, Remondegui C, Ceballos S, Echenique G, Charre Samman M, D'Amico C, Rojas A, Martínez A, Ridruejo E, Fernández RJ, Burgos Pratx L, Salamone H, Nuñez F, Galdame O, Gadano A, Corach D, Sugiyama M, Flichman D, Tokunaga K, Mizokami M. Liver Int; 2017 Oct 23; 37(10):1476-1487. PubMed ID: 28267888 [Abstract] [Full Text] [Related]
17. [Studies on the association of single nucleotide polymorphisms of HLA-DP and DQ genes with the outcome of chronic hepatitis B virus infection]. Su M, Zeng Y, Chen J, Jiang L, Chen T, Liu C, Yang B, Ou Q. Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2014 Dec 23; 31(6):765-9. PubMed ID: 25449085 [Abstract] [Full Text] [Related]
19. Relationship between HLA-DP gene polymorphisms and clearance of chronic hepatitis B virus infections: case-control study and meta-analysis. Yan Z, Tan S, Dan Y, Sun X, Deng G, Wang Y. Infect Genet Evol; 2012 Aug 23; 12(6):1222-8. PubMed ID: 22543033 [Abstract] [Full Text] [Related]
20. HLA-DP polymorphisms affect the outcomes of chronic hepatitis B virus infections, possibly through interacting with viral mutations. Zhang Q, Yin J, Zhang Y, Deng Y, Ji X, Du Y, Pu R, Han Y, Zhao J, Han X, Zhang H, Cao G. J Virol; 2013 Nov 23; 87(22):12176-86. PubMed ID: 24006435 [Abstract] [Full Text] [Related] Page: [Next] [New Search]